where effectors bind effector where does it bind? at the active site substrate product competitive...

20
Where Effectors Bind Effector where does it bind? At the Active Site At another site substrate product competitive inhibitor irreversible inhibitor "designed site" "incidental site" allosteric inhibitor allosteric activator irreversible inhibitor noncompetitive inhibitor irreversible inhibitor Uncompetitive inhibitor

Upload: vanessa-casey

Post on 04-Jan-2016

227 views

Category:

Documents


5 download

TRANSCRIPT

Page 1: Where Effectors Bind Effector where does it bind? At the Active Site substrate product competitive inhibitor irreversible inhibitor At another site "designed

Where Effectors BindWhere Effectors Bind

Effector

where does it bind?

At theActive Site

At another site

substrateproduct

competitiveinhibitor

irreversible inhibitor

"designed site"

"incidental site"

allostericinhibitor

allostericactivator

irreversibleinhibitor

noncompetitiveinhibitor

irreversibleinhibitor

Uncompetitive inhibitor

Page 2: Where Effectors Bind Effector where does it bind? At the Active Site substrate product competitive inhibitor irreversible inhibitor At another site "designed

Inhibitors - Simple EnzymesInhibitors - Simple Enzymes

Competitive Inhibitor - Has a shape similar to that of the substrate and binds to the active site of the enzyme and prevents the substrate from binding.

Noncompetitive Inhibitor - Binds at a another site on the enzyme other than the active site not dependent on substrate binding not the same as allosteric!

Uncompetitive Inhibitor - Binds at a another site on the enzyme other than the active site dependent on substrate binding not the same as allosteric

Irreversible Inhibition - Occurs when an inhibitor forms a covalent bond to the enzyme and inhibits its activity.

Page 3: Where Effectors Bind Effector where does it bind? At the Active Site substrate product competitive inhibitor irreversible inhibitor At another site "designed

Competitive Inhibition ICompetitive Inhibition I

•Inhibitor and substrate have portion of shape in common•Compete for active site•Large amounts of inhibitor swamp out substrate binding and product formation is suppressed•Likewise large amounts of substrate swamp out inhibitor binding and product formation is minimized

Page 4: Where Effectors Bind Effector where does it bind? At the Active Site substrate product competitive inhibitor irreversible inhibitor At another site "designed

Competitive Inhibition IICompetitive Inhibition II

•As the amount of inhibitor increases, there is more competition at the active site

• most pronounced at low levels of S

•At higher [S], inhibition is “swamped out”•Vmax does not change

• processing rate not effected•“Km” increases!!!

• the enzyme does not bind the substrate as well in the presence of inhibitor

Competitive InhibitionVelocity vs [Substrate]

0.00

0.20

0.40

0.60

0.80

1.00

1.20

1.40

1.60

0.00 0.50 1.00 1.50 2.00

substrate concentration [S]

Init

ial v

elo

city

[I] = 0 [I] = x [I] = 2x

Page 5: Where Effectors Bind Effector where does it bind? At the Active Site substrate product competitive inhibitor irreversible inhibitor At another site "designed

Competitive InhibitionLineweaver-Burk Inverse Plot

y = 0.2457x + 1.0103

y = 0.3983x + 0.9819

y = 0.6194x + 0.9995

0

1

2

3

4

5

6

7

8

-5 0 5 10 15

1/substrate concentration [S]-1

1/in

itial

vel

ocity

Competitive Inhibition IIICompetitive Inhibition III

[I] = x

[I] =2x

A Lineweaver-Burk plotallows the importantparameters, Km and Vmax, to be determined directlyfrom an equation ratherthan from an extrapolation

1/Vmax = y intercept

Km/Vmax = slope of line

Get Vmax first, don’t forget inverserelationship!!!Highest line most inhibited!!!!

[I] = 0

Page 6: Where Effectors Bind Effector where does it bind? At the Active Site substrate product competitive inhibitor irreversible inhibitor At another site "designed

Noncompetitive Inhibition INoncompetitive Inhibition I

•Inhibitor and substrate DO NOT have common shape•Binding is NOT at active site but causes a change in the substrate binding site•Large amounts of inhibitor prevent access of substrate to binding site•Large amounts of substrate CANNOT overcome inhibitory effect

Page 7: Where Effectors Bind Effector where does it bind? At the Active Site substrate product competitive inhibitor irreversible inhibitor At another site "designed

Noncompetitive Inhibition IINoncompetitive Inhibition II

•As the amount of inhibitor increases, the efficiency of processing the product decreases

• same relative effect at all levels of S

•Higher [S] cannot “swamp out” effect; the “problem” is not at active site•Km does not change

• binding/dissociation not effected

•“Vmax ” decreases •the enzyme is less efficient in processing product

Noncompetitive InhibitionVelocity vs [Substrate]

0.000

0.100

0.200

0.300

0.400

0.500

0.600

0.700

0.800

0.900

0.000 0.200 0.400 0.600 0.800 1.000 1.200

substrate concentration [S]

Initi

al v

eloc

ity

[I] = 0

[I] = 2x

[I] = x

Page 8: Where Effectors Bind Effector where does it bind? At the Active Site substrate product competitive inhibitor irreversible inhibitor At another site "designed

Noncompetitive InhibitionLineweaver-Burk Inverse Plot

y = 0.2461x + 1.0077

y = 0.307x + 1.2354

y = 0.4504x + 1.7139

0

1

2

3

4

5

6

7

-5 0 5 10 15

1/substrate concentration [S]-1

1/in

itia

l ve

loci

ty

Noncompetitive Inhibition IIINoncompetitive Inhibition III

A Lineweaver-Burk plotallows the importantparameters, Km and Vmax, to be determined directlyfrom an equation ratherthan from an extrapolation

1/Vmax = y intercept

Km/Vmax = slope of line

Get Vmax first, don’t forget inverserelationship!!!Highest line most inhibited!!!

[I] = 0

[I] = 2x

[I] = x

Page 9: Where Effectors Bind Effector where does it bind? At the Active Site substrate product competitive inhibitor irreversible inhibitor At another site "designed

Uncompetitive Inhibition IUncompetitive Inhibition I

•Inhibitor and substrate DO NOT have common shape•Binding is NOT at active site •Binding of substrate causes a change in the shape of the enzyme that allows inhibitor to bind•Inhibitor binding prevents processing of substrate to product•Larger amounts of substrate cannot overcome inhibitory effect

Page 10: Where Effectors Bind Effector where does it bind? At the Active Site substrate product competitive inhibitor irreversible inhibitor At another site "designed

Uncompetitive Inhibition IUncompetitive Inhibition I

As the amount of inhibitorincreases:

• the binding is effected• the efficiency of processing product decreases

Km increases•binding/dissociation effected

“Vmax ” decreases •the enzyme is less efficient in processing product

BC Online:  6B - Models of Enzyme Inhibition

Page 11: Where Effectors Bind Effector where does it bind? At the Active Site substrate product competitive inhibitor irreversible inhibitor At another site "designed

Controls of Enzymatic ActivityControls of Enzymatic Activity

Inductive effects changing the amount of active enzyme present genetic control; irreversible covalent modification

Regulatory effects changing the activity of enzymes already present LeChatelier control; allosteric control; reversible

covalent modification; hormonal control

Page 12: Where Effectors Bind Effector where does it bind? At the Active Site substrate product competitive inhibitor irreversible inhibitor At another site "designed

Inductive EffectsInductive Effects

Genetic control Turn genes on make mRNA make enzymes

Irreversible covalent modification Proteolytic activation zymogen ----> active enzyme very common for digestive enzymes

Page 13: Where Effectors Bind Effector where does it bind? At the Active Site substrate product competitive inhibitor irreversible inhibitor At another site "designed

Regulatory effectsRegulatory effects

LeChatelier every system responds to the levels of substrates and products

Allosteric feedback: product of pathway providing information about the status of

metabolism forward activation: the product of an earlier reaction telling a later enzyme to

get ready Reversible covalent modification

reversible phosphorylation usually on serine extra ramping up of enzymatic activity, sometimes related to hormonal

response; control points in metabolic pathways Hormonal control

control from a distance (on organism level) binding to outside of cell OR entry into cell causes effect

Page 14: Where Effectors Bind Effector where does it bind? At the Active Site substrate product competitive inhibitor irreversible inhibitor At another site "designed

Feedback InhibitionFeedback Inhibition

“Information” from a later step in pathway Usually product of

downstream reaction Amount of

product has to build up before effect is “felt” Utilization of

downstream product decreases effect

Page 15: Where Effectors Bind Effector where does it bind? At the Active Site substrate product competitive inhibitor irreversible inhibitor At another site "designed

Forward ActivationForward Activation

“Information” from an earlier step in pathway Usually substrate of

upstream reaction Signal that lots of stuff

is on the way Amount of substrate

has to build up before effect is “felt” Utilization of upstream

substrate decreases effect

Page 16: Where Effectors Bind Effector where does it bind? At the Active Site substrate product competitive inhibitor irreversible inhibitor At another site "designed

Factors Influencing the Rates of Enzyme-Catalyzed ReactionsFactors Influencing the Rates of Enzyme-Catalyzed Reactions

Concentration of the substrateConcentration of the substrate

0.0

0.2

0.4

0.6

0.8

1.0

Rat

e

0.0 5.0 10.0 15.0 20.0 25.0 30.0

Substrate Concentration

Rate versus Concentration of Substrate

Most Enzymes

Rate

Substrate Concentration

Rate versus Concentration of Substrate

Allosteric Enzyme

Page 17: Where Effectors Bind Effector where does it bind? At the Active Site substrate product competitive inhibitor irreversible inhibitor At another site "designed

Allosteric Regulation of Enzyme ActivityAllosteric Regulation of Enzyme Activity

Allosteric Enzymes - Enzymes composed of two or more protein chains which contain separate regulatory sites and active sites. Often the regulatory site is on one chain and the active

site on another. Binding of a molecule at the regulatory site changes the

shape of the enzyme and affects its activity. Activator - a positive regulator Allosteric inhibitor - a negative regulator

not the same as noncompetitive inhibition

Page 18: Where Effectors Bind Effector where does it bind? At the Active Site substrate product competitive inhibitor irreversible inhibitor At another site "designed

Concerted Model of Allosteric EffectConcerted Model of Allosteric Effect

T

T R

R

L

• The substrate, , can only bind to the Relaxed (R) form of the enzyme• The Taut (T) and Relaxed (R) forms are in equilibrium with each other with an equilibrium constant value of L

L = [R]/[T]

• The value of L is much less than 1• As the concentration of increases, equilibrium is shifted to the right• Since L remains constant, more of the T form is converted to the R form and there is more enzyme in the R form and the reaction speeds up

R

R

Page 19: Where Effectors Bind Effector where does it bind? At the Active Site substrate product competitive inhibitor irreversible inhibitor At another site "designed

Sequential Model of Allosteric EffectSequential Model of Allosteric Effect

T

T R

R

L• The substrate, , can bind to both the Relaxed (R)and Taut (T) forms of the enzyme• The R form is bound preferentially• Only the site that has bound the substrate changes conformation by induced fit•The binding of the initial substrate passes on the conformational change to other subunits• These units will now bind the substrate with greater ease•As the concentration of increases, the number of relaxed active sites increases and the reaction speeds up sigmoidally form and the reaction speeds up

R

R

R

T

Page 20: Where Effectors Bind Effector where does it bind? At the Active Site substrate product competitive inhibitor irreversible inhibitor At another site "designed

“Sense” of Cooperativity“Sense” of Cooperativity

every protein is in its lowest energy configuration given the prevailing conditions

the "resting" form of an enzyme is in the taut form either in equilibrium with relaxed form or can be changed to the relaxed form when substrate is added (or increased) this is the “turtle in its shell mode” -it is safe

the relaxed form becomes more favored upon the addition of substrate (or activator) the prevailing conditions have changed! “turtle in its moving and eating mode”- also more vulnerable!